Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcripts identified by microarray analysis that were deregulated in E15.5+6d Tbx18(cre/+);FGFR1(fl/fl);FGFR2(fl/fl) (Fgfr1/2cDKO) ureter cultures

ABSTRACT: Evaluation of the transcriptional changes in E15.5+6d ureter cultures upon loss of Fgfr1 and Fgfr2 in the ureteric mesenchyme.

ORGANISM(S): Mus musculus

PROVIDER: GSE197368 | GEO | 2022/09/06

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Transcripts identified by microarray analysis that were deregulated in E14.5 Tbx18(cre/+);FGFR1(fl/fl);FGFR2(fl/fl) (Fgfr1/2cDKO) ureters

Project description:Evaluation of the transcriptional changes in E14.5 ureters upon loss of Fgfr1 and Fgfr2 in the ureteric mesenchyme.

2022-09-06 | GSE197369 | GEO

Transcripts identified by microarray analysis that were deregulated in E13.5 Pax-2cre;Fgfr1(fl/?);Fgfr2(fl/fl) (Fgfr2cKO) ureters.

Project description:Evaluation of the transcriptional changes in E13.5 ureters upon loss of Fgfr2 (and reduction of Fgfr1) in the ureteric epithelium.

2022-01-04 | GSE178093 | GEO

Transcripts identified by microarray analysis that were deregulated in E14.5 Tbx18(cre/+);Gata6(fl/fl) (Gata6cKO) ureters

Project description:Evaluation of the transcriptional changes in E14.5 ureters upon loss of Gata6 in the ureteric mesenchyme.

2022-01-04 | GSE174614 | GEO

Transcripts identified by microarray analysis that were deregulated in E18.5 Tbx18(cre/+);Rbpj(fl/fl) (Rbpj-cKO) ureters

Project description:Evaluation of the transcriptional changes in E18.5 ureters upon loss of Rbpj in the ureteric mesenchyme.

2022-01-04 | GSE169662 | GEO

Transcripts identified by microarray analysis that were deregulated in E14.5 Tbx18(cre/+);Rbpj(fl/fl) (Rbpj-cKO) ureters

Project description:Evaluation of the transcriptional changes in E14.5 ureters upon loss of Rbpj in the ureteric mesenchyme.

2022-01-04 | GSE169661 | GEO

RNA-Seq of human glioblastoma cells with knockdown of FGFR1 or FGFR2

Project description:Human glioblastoma cell lines L0, L1, L2 (Deleyrolle et al. Brain 2010) were transduced with lentivirus vectors expressing scrambled control (shCo), FGFR1 knockdown (shFGFR1), or FGFR2 knockdown (shFGFR2) sequences. Cells were cultured in N2 medium containing EGF and stimulated with FGF2 for 48 hours prior to RNA extraction.

2023-08-29 | E-MTAB-13161 | biostudies-arrayexpress

Human Ureter project - A proteomic glimpse into human ureter proteome

Project description:The data includes Human ureter protome fractionated into 10 fractions and subjected to insolution digestion

2015-07-31 | PXD002620 | Pride

Phosphoproteomics of truncated FGFR2, a clinically actionable oncogene in multiple cancers

Project description:Somatic hotspot mutations and structural amplifications and fusions affecting fibroblast growth factor receptor 2 (FGFR2) occur in multiple cancer types. However, clinical responses to FGFR inhibitors (FGFRi) have remained variable, emphasizing a need to better understand which FGFR2 alterations are oncogenic and targetable. Here we applied transposon-based screening and tumor modelling in mice to uncover truncation of exon (E) 18 of Fgfr2 as a potent driver mutation. Human oncogenomic datasets revealed a diverse set of FGFR2 alterations, including rearrangements (REs), E1-E17 partial amplifications, and E18 nonsense and frameshift mutations, each causing transcription of E18-truncated FGFR2 (FGFR2deltaE18). Somatic modelling in mice and human tumor cell lines using a compendium of FGFR2deltaE18 and full-length variants identified FGFR2deltaE18-truncation as potent single-driver alteration in cancer. Here we show the phosphoproteomic landscape of FGFR2 variants in murine epithelial cell (MEC) lines and mouse tumors. Global (STY) phosphoproteomics using IMAC and phosphotyrosine phosphoproteomics using pTyr IP’s are combined with DIA protein expression data to uncover oncogenic signaling of clinically-relevant FGFR2 variants.

2022-06-06 | PXD031711 | Pride

Stimulation of endogenous FGFR2 signalling in MCF-7 cells following knock-down of FGFR2

Project description:Genome-wide association studies have identified a locus within the second intron of the FGFR2 gene that is consistently the most strongly associated with estrogen receptor-poisive breast cancer risk. However, we know little about the mechanisms by which the FGFR2 locus mediates risk or the pathways in which multiple risk loci may combine to cause disease. Previously, a systems biology approach was adopted to elucidate the regulatory networks operating in MCF-7 breast cancer cells in order to examine the role of FGFR2 in mediating risk. Here, the same approach has been employed using MCF-7 cells that have been treated with siRNA directed against FGFR2, in order to knock-down FGFR2 expression, to confirm that the differential gene expression that we see when FGF10 signalling is perturbed, on a background of estrogen signalling, is mediated via FGFR2 stimulation.

2016-02-01 | GSE74146 | GEO

ATAC-seq from ureter (ENCSR814RGG)

Project description:ATAC-seq on human ureter For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2022-10-16 | GSE215482 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data